Allergy/Asthma News

The Allergy & Asthma Network praised three major pharmaceutical companies, AstraZeneca, Boehringer Ingelheim and GSK, that announced they will enact a $35 price cap on their inhaler products.

As spring begins, patients with tree, grass and weed allergies may have to cope with oral allergy syndrome, which arises from an allergic reaction to certain fresh or raw foods, including vegetables, fruits and nuts, a specialist said.

The FDA approved Xhance for the treatment of chronic rhinosinusitis without nasal polyps among patients aged 18 years and older.

Patients with prior sinusitis demonstrate an increased risk for many rheumatic diseases, including antiphospholipid syndrome, Sjögren’s disease and seronegative rheumatoid arthritis, according to data published in RMD Open.

At the American Academy of Allergy, Asthma & Immunology Annual Meeting, an expert shared ways in which patients can control their pet allergy symptoms without removing pets from the home.

Practice owners and directors should familiarize themselves with local and federal employment laws because the penalties for noncompliance can be severe, according to employment lawyer Penelope J. Phillips, JD.

Robert Wood, MD, FAAAAI, professor of pediatrics Johns Hopkins University School of Medicine, recounted the results of the OUtMATCH study.

A high risk for asthma in children was linked to increased levels of fine particulate matter and nitrogen dioxide exposure in the first 3 years of life, according to results published in JAMA Network Open.

WASHINGTON — Most physicians believed that needle-free epinephrine delivery would be preferable among patients, and that it would lead to more patients carrying it and using it faster, survey results showed.

WASHINGTON — A nurse-led intervention improved pediatric food allergy knowledge, although it also revealed “concerning” shortcomings in certain areas of identification and management, research showed.